A rise in the average age of biomedical researchers might inhibit research potential and novel projects that could impact biomedicine and the next generation of scientists in the United States.
The NIH, which has an annual budget of over US$31 billion, is the world’s largest biomedical research agency and is a major strength for science in the U.S. Despite the political nature of stem cell research, this area of science has flourished across the country. In 2010, the NIH funded approximately US$1.3 billion in stem cell research. According to the ISI Web of Science, more than 4,000 U.S.-authored stem cell publications were produced in 2010 — approximately 40% of the world total. The average citation rate was 4.12 per article, with six articles amassing 100 citations in less than 18 months after release.
Kirstin Matthews, fellow in science and technology, answers questions regarding the biology, practical uses and ethical dilemmas surrounding stem cells.
Over the past decade, the U.S. human embryonic stem cell (hESC) policy has become a hodgepodge of difficult-to-understand and easily misinterpreted legislation and regulations.
Kirstin R.W. Matthews, Neal F. LaneOctober 12, 2007
A program to bring together scientists, ethicists, policymakers, media experts, and community and business leaders to find new ways to engage the general public in a dialogue on international stem cell policies and the ethical use of stem cells for research.